1. Home
  2. BTG vs VRNA Comparison

BTG vs VRNA Comparison

Compare BTG & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BTG
  • VRNA
  • Stock Information
  • Founded
  • BTG 2006
  • VRNA 2005
  • Country
  • BTG Canada
  • VRNA United Kingdom
  • Employees
  • BTG N/A
  • VRNA N/A
  • Industry
  • BTG Precious Metals
  • VRNA Biotechnology: Pharmaceutical Preparations
  • Sector
  • BTG Basic Materials
  • VRNA Health Care
  • Exchange
  • BTG Nasdaq
  • VRNA Nasdaq
  • Market Cap
  • BTG 4.2B
  • VRNA 3.4B
  • IPO Year
  • BTG N/A
  • VRNA 2017
  • Fundamental
  • Price
  • BTG $2.39
  • VRNA $51.89
  • Analyst Decision
  • BTG Buy
  • VRNA Strong Buy
  • Analyst Count
  • BTG 3
  • VRNA 7
  • Target Price
  • BTG $4.02
  • VRNA $50.57
  • AVG Volume (30 Days)
  • BTG 15.1M
  • VRNA 1.4M
  • Earning Date
  • BTG 02-19-2025
  • VRNA 02-27-2025
  • Dividend Yield
  • BTG 5.02%
  • VRNA N/A
  • EPS Growth
  • BTG N/A
  • VRNA N/A
  • EPS
  • BTG N/A
  • VRNA N/A
  • Revenue
  • BTG $1,914,216,000.00
  • VRNA $5,624,000.00
  • Revenue This Year
  • BTG $2.67
  • VRNA N/A
  • Revenue Next Year
  • BTG $41.99
  • VRNA $550.30
  • P/E Ratio
  • BTG N/A
  • VRNA N/A
  • Revenue Growth
  • BTG N/A
  • VRNA 1127.95
  • 52 Week Low
  • BTG $2.32
  • VRNA $11.39
  • 52 Week High
  • BTG $3.50
  • VRNA $55.42
  • Technical
  • Relative Strength Index (RSI)
  • BTG 36.50
  • VRNA 64.25
  • Support Level
  • BTG $2.34
  • VRNA $43.44
  • Resistance Level
  • BTG $2.53
  • VRNA $55.42
  • Average True Range (ATR)
  • BTG 0.09
  • VRNA 3.32
  • MACD
  • BTG -0.00
  • VRNA 0.40
  • Stochastic Oscillator
  • BTG 19.44
  • VRNA 70.52

About BTG B2Gold Corp Common shares (Canada)

B2Gold Corp is an international, low-cost, senior gold mining company. It has three operating open-pit gold mines in Mali, Namibia, and the Philippines and numerous exploration projects across four continents. Other significant assets include the Gramalote and Kiaka gold projects. The company focuses on acquiring and developing interests in mineral properties with a primary focus on gold deposits as gold production forms all its revenue. There is no dependence on a particular purchaser because the gold is sold into a global market. The company's reportable operating segments include its mining operations and development projects, namely Fekola; Masbate; Otjikoto; the Goose Project, and other mineral properties; and corporate and other.

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

Share on Social Networks: